Early Childhood Obesity Programming by Intrauterine Growth Restriction

Part of paid clinical trials in The Bronx, New York.

Sponsor
Montefiore Medical Center
Study ID
NCT03402139
Status
Recruiting
Apply to this trial

Conditions

  • Childhood Obesity
  • Epigenetics

Eligibility Criteria

Sex
ALL
Age
1 Hour - 24 Months
Healthy Volunteers
Accepted

Study Details

The molecular mechanisms underlying developmental programming of childhood obesity remain poorly understood. Here, the investigators address major questions about early childhood obesity programming by studying CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased risk for obesity and other metabolic disorders in adult life.

Key Dates

Start date
Sep 1, 2018
Status verified
Sep 2025
Primary completion
Mar 31, 2028
Completion
Mar 31, 2028

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: IUGR infants
    Intrauterine growth restricted infants will be enrolled. There are no interventions.
  • Arm: AGA infants
    Appropriate for gestational age infants will be enrolled. There are no interventions.

Primary Outcome Measure

Growth velocity [ Time Frame: Until 24 months of age ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Jack D. Weiler HospitalThe BronxNew York10461
Mamta Fuloria, MD
[email protected]
718-904-4105

Find similar trials in The Bronx, NY

By research site
Jack D. Weiler Hospital· The Bronx, NY

Related Studies